DB
Digital Biotechnologies, Inc.
SEC filingBiotechnology · Seattle, WA
Amount raised$12.3Msold at filing
Total offering$15M$2.7M still open
Investors in the raise61count reported to the SEC
FiledDec 31, 2025first sale Dec 17, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Harlan RobinsDirector
Chad RobinsExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.